Scientists test safety of new Multi-Drug cocktails for tough cancers
NCT ID NCT03307785
Summary
This early-stage study aimed to find safe doses for several different combinations of cancer drugs in patients with advanced or metastatic solid tumors, including lung cancer. The 60 participants were divided into groups to test combinations of chemotherapy, immunotherapy, and targeted drugs. The main goal was to check for serious side effects to determine which doses could be used in larger, future studies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
GSK Investigational Site
Scottsdale, Arizona, 85258, United States
-
GSK Investigational Site
Encinitas, California, 92024, United States
-
GSK Investigational Site
San Marcos, California, 92069, United States
-
GSK Investigational Site
Sarasota, Florida, 34232, United States
-
GSK Investigational Site
Canton, Ohio, 44718, United States
-
GSK Investigational Site
Cleveland, Ohio, 44106, United States
-
GSK Investigational Site
Nashville, Tennessee, 37203, United States
-
GSK Investigational Site
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.